Childhood acute lymphoblastic leukemia with hyperleukocytosis at presentation

Blood Research

Volumn 49, Issue 1, 2014, Pages 29-35

  Kong, Seom Gim ^a   Seo, Jung Ho ^a   Jun, So Eun ^a   Lee, Byung Ki ^a   Lim, Young Tak ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

Central nervous system hemorrhage; Hyperleukocytosis; Pediatric acute lymphoblastic leukemia

Indexed keywords

ALLOPURINOL; ALUMINUM HYDROXIDE; ASPARAGINASE; CALCIUM; CREATININE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; HEMOGLOBIN; HLA ANTIGEN; INFUSION FLUID; LACTATE DEHYDROGENASE; MERCAPTOPURINE; METHOTREXATE; PHOSPHORUS; POTASSIUM; PREDNISOLONE; URIC ACID; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALKALINIZATION; ARTICLE; B LYMPHOCYTE; BENIGN CHILDHOOD EPILEPSY; BONE MARROW; BRAIN HEMORRHAGE; CALCIUM BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME TRANSLOCATION; CONSOLIDATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOGENETICS; EARLY CANCER; EVENT FREE SURVIVAL; FEMALE; GENDER; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERKALEMIA; HYPERLEUKOCYTOSIS; HYPERPHOSPHATEMIA; HYPOCALCEMIA; IMMUNOPHENOTYPING; INDUCTION CHEMOTHERAPY; KIDNEY DYSFUNCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LEUKOCYTOSIS; MAINTENANCE CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRE B LYMPHOCYTE; PRESCHOOL CHILD; SCHOOL CHILD; SIBLING; SPLENOMEGALY; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; THROMBOCYTE COUNT; TREATMENT DURATION; TUMOR LYSIS SYNDROME; URIC ACID BLOOD LEVEL;

EID: 84896969196     PISSN: 2287979X     EISSN: 22880011     Source Type: Journal    
DOI: 10.5045/br.2014.49.1.29     Document Type: Article

References (18)

1. Wald BR, Heisel MA, Ortega JA. Frequency of early death in children with acute leukemia presenting with hyperleukocytosis. Cancer 1982;50:150-3.
2. Harousseau JL, Tobelem G, Schaison G, et al. High risk acute lymphocytic leukemia: a study of 141 cases with initial white blood cell counts over 100,000/cu mm. Cancer 1980;46:1996-2003.
3. Eguiguren JM, Schell MJ, Crist WM, Kunkel K, Rivera GK. Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis. Blood 1992;79:871-5.
4. Maurer HS, Steinherz PG, Gaynon PS, et al. The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia. J Clin Oncol 1988;6:1425-32.
5. Lowe EJ, Pui CH, Hancock ML, Geiger TL, Khan RB, Sandlund JT. Early complications in children with acute lymphoblastic leuke-mia presenting with hyperleukocytosis. Pediatr Blood Cancer 2005;45:10-5.
6. Majhail NS, Lichtin AE. Acute leukemia with a very high leukocyte count: confronting a medical emergency. Cleve Clin J Med 2004;71:633-7.
7. Porcu P, Farag S, Marcucci G, Cataland SR, Kennedy MS, Bissell M. Leukocytoreduction for acute leukemia. Ther Apher 2002;6:15-23.
8. Porcu P, Cripe LD, Nq EW, et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma 2000;39:1-18.
9. Hoelzer D, Thiel E, Loffler H, et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988;71:123-31.
10. Ganzel C, Becker J, Mintz PD, Lazarus HM, Rowe JM. Hyper-leukocytosis, leukostasis and leukapheresis: practice manage-ment. Blood Rev 2012;26:117-22.
11. Kulkarni KP, Marwaha RK. Childhood acute lymphoblastic leukemia with hyperleukocytosis at presentation: perspective and lessons from a tertiary care institution in India. Asia Pac J Clin Oncol 2011;7:185-7.
12. Bunin NJ, Pui CH. Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia. J Clin Oncol 1985;3:1590-5.
13. Bug G, Anargyrou K, Tonn T, et al. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis. Transfusion 2007;47:1843-50.
14. Giles FJ, Shen Y, Kantarjian HM, et al. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival. Leuk Lymphoma 2001;42:67-73.
15. Porcu P, Danielson CF, Orazi A, Heerema NA, Gabig TG, McCarthy LJ. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate. Br J Haematol 1997;98:433-6.
16. Holig K, Moog R. Leukocyte depletion by therapeutic leuko-cytapheresis in patients with leukemia. Transfus Med Hemother 2012;39:241-5.
17. Szczepiorkowski ZM, Winters JL, Bandarenko N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010;25:83-177.
18. Dutcher JP, Schiffer CA, Wiernik PH. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol 1987;5:1364-72.